162 related articles for article (PubMed ID: 24411591)
1. Treatment for salivary gland hypofunction at both initial and advanced stages of Sjögren-like disease: a comparative study of bone marrow therapy versus spleen cell therapy with a 1-year monitoring period.
Khalili S; Faustman DL; Liu Y; Sumita Y; Blank D; Peterson A; Kodama S; Tran SD
Cytotherapy; 2014 Mar; 16(3):412-23. PubMed ID: 24411591
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow cells are a source of undifferentiated cells to prevent Sjögren's syndrome and to preserve salivary glands function in the non-obese diabetic mice.
Khalili S; Liu Y; Sumita Y; Maria OM; Blank D; Key S; Mezey E; Tran SD
Int J Biochem Cell Biol; 2010 Nov; 42(11):1893-9. PubMed ID: 20732442
[TBL] [Abstract][Full Text] [Related]
3. Reversal of Sjogren's-like syndrome in non-obese diabetic mice.
Tran SD; Kodama S; Lodde BM; Szalayova I; Key S; Khalili S; Faustman DL; Mezey E
Ann Rheum Dis; 2007 Jun; 66(6):812-4. PubMed ID: 17179174
[TBL] [Abstract][Full Text] [Related]
4. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sjögren's-like disease.
Khalili S; Liu Y; Kornete M; Roescher N; Kodama S; Peterson A; Piccirillo CA; Tran SD
PLoS One; 2012; 7(6):e38615. PubMed ID: 22685592
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjögren syndrome.
Baban B; Liu JY; Abdelsayed R; Mozaffari MS
Exp Mol Pathol; 2013 Dec; 95(3):288-97. PubMed ID: 24060278
[TBL] [Abstract][Full Text] [Related]
7. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
8. Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
Lodde BM; Mineshiba F; Wang J; Cotrim AP; Afione S; Tak PP; Baum BJ
Ann Rheum Dis; 2006 Feb; 65(2):195-200. PubMed ID: 15975969
[TBL] [Abstract][Full Text] [Related]
9. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
11. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.
Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ
Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769
[TBL] [Abstract][Full Text] [Related]
12. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
13. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Kreiger PA; Lieberman SM
Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
[TBL] [Abstract][Full Text] [Related]
14. Non-proliferating plasma cells detected in the salivary glands and bone marrow of autoimmune NOD.B10.H2b mice, a model for primary Sjögren's syndrome.
Szyszko EA; Aqrawi LA; Jonsson R; Brokstad KA; Skarstein K
Autoimmunity; 2016; 49(1):41-9. PubMed ID: 26324998
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
Li N; Shigihara T; Tzioufas AG; Notkins AL; Yoon JW; Jun HS
Arthritis Rheum; 2007 Jul; 56(7):2211-5. PubMed ID: 17599739
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of primary Sjögren syndrome].
Saraux A; Jousse-Joulin S; Devauchelle-Pensec V
Rev Prat; 2012 Feb; 62(2):234-8. PubMed ID: 22408873
[TBL] [Abstract][Full Text] [Related]
18. Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.
Gervais EM; Desantis KA; Pagendarm N; Nelson DA; Enger T; Skarstein K; Liaaen Jensen J; Larsen M
Anat Rec (Hoboken); 2015 Sep; 298(9):1622-34. PubMed ID: 26179322
[TBL] [Abstract][Full Text] [Related]
19. Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome.
Kok MR; Yamano S; Lodde BM; Wang J; Couwenhoven RI; Yakar S; Voutetakis A; Leroith D; Schmidt M; Afione S; Pillemer SR; Tsutsui MT; Tak PP; Chiorini JA; Baum BJ
Hum Gene Ther; 2003 Nov; 14(17):1605-18. PubMed ID: 14633403
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord mesenchymal stem cells improve disease characterization of Sjogren's syndrome in NOD mice through regulation of gut microbiota and Treg/Th17 cellular immunity.
Zou Y; Xiao W; Liu D; Li X; Li L; Peng L; Xiong Y; Gan H; Ren X
Immun Inflamm Dis; 2024 Jan; 12(1):e1139. PubMed ID: 38270310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]